Published in Circulation on December 01, 1983
Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J (1989) 1.70
Adenosine stimulates respiration in man. Br J Clin Pharmacol (1985) 1.67
Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol (2009) 1.56
Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol (1988) 1.46
Transient bradycardia and subsequent sinus tachycardia produced by intravenous adenosine in healthy adult subjects. Br J Clin Pharmacol (1986) 1.29
Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole. Br J Clin Pharmacol (1986) 1.16
Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J (Clin Res Ed) (1986) 1.06
Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J (1993) 1.06
An introduction to murine models of atrial fibrillation. Front Physiol (2012) 0.92
Adenosine causes transient dilatation of coronary arteries in man. Br J Clin Pharmacol (1987) 0.90
Adenosine: an importance beyond ATP. Br Med J (Clin Res Ed) (1986) 0.89
Circulatory and respiratory effects of infused adenosine in conscious man. Br J Clin Pharmacol (1987) 0.89
Comparative transcriptome analysis of Bacillus subtilis responding to dissolved oxygen in adenosine fermentation. PLoS One (2011) 0.88
Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism. J Clin Invest (1988) 0.87
Reflex increase in blood pressure during the intracoronary administration of adenosine in man. J Clin Invest (1989) 0.82
Cardiac purinergic signalling in health and disease. Purinergic Signal (2014) 0.81
Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells. Br J Pharmacol (1996) 0.81
Heterogeneity of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis. Br J Pharmacol (1989) 0.79
Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs. Br J Pharmacol (1992) 0.78
Isoprenaline and inducibility of atrioventricular nodal re-entrant tachycardia. Heart (1998) 0.78
Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla. J Cardiovasc Magn Reson (2015) 0.78
Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction. Br J Pharmacol (1991) 0.77
Adenosine receptors and nucleoside transport sites in cardiac cells. Br J Pharmacol (1991) 0.77
Studies of the nucleoside transporter inhibitor, draflazine, in the human myocardium. Br J Pharmacol (1994) 0.76
Dose-dependent pulmonary vein reconnection in response to adenosine: relevance of atrioventricular block during infusion. J Interv Card Electrophysiol (2016) 0.75
Angina pectoris-like pain provoked by intravenous infusion of adenosine. Br Med J (Clin Res Ed) (1986) 0.75
Effects of adenosine on electrical activity of isolated guinea pig hearts. Basic Res Cardiol (1993) 0.75
Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy. Heart (1999) 0.75
Clinical characteristics of hypervagotonic sinus node dysfunction. Korean J Intern Med (2004) 0.75
Treatment of paroxysmal supraventricular tachycardia with intravenous injection of adenosine triphosphate. Br Heart J (1986) 0.75
Adenosine-induced tachycardia acceleration: an unusual proarrhythmia. BMJ Case Rep (2015) 0.75
Comparison of the effects of adenosine, inosine, and their combination as an adjunct to reperfusion in the treatment of acute myocardial infarction. ISRN Cardiol (2012) 0.75
Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts. Postgrad Med J (1988) 0.75
Abstracts: annual meeting of the Canadian Anesthetists' Society. June 26-29, 1988, Halifax, Nova Scotia. Can J Anaesth (1988) 0.75
Clinical Significance of the Forsaken aVR in Evaluation of Tachyarrhythmias: A Reminder. J Clin Diagn Res (2017) 0.75
What Else Can CD39 Tell Us? Front Immunol (2017) 0.75
Adenosine for the treatment of sustained sinus nodal reentrant tachycardia during general anesthesia. J Anesth (1995) 0.75
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
The role of adenosine in the regulation of coronary blood flow. Circ Res (1980) 2.97
Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol (1999) 2.91
Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24
Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem (1979) 2.23
Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med (1979) 2.20
The cardiac effects of adenosine. Prog Cardiovasc Dis (1989) 2.20
Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol (1999) 2.11
Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol (1994) 2.09
Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance. Circ Res (1969) 2.04
Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow. Circ Res (1970) 2.02
Release of adenosine in reactive hyperemia of the dog heart. Am J Physiol (1969) 1.99
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol (1997) 1.88
Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol (1983) 1.86
The evaluation and management of bradycardia. N Engl J Med (2000) 1.79
Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology (1993) 1.75
Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol (1996) 1.67
Protective effects of adenosine in myocardial ischemia. Circulation (1992) 1.66
Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ Res (1979) 1.65
A2A-adenosine receptor reserve for coronary vasodilation. Circulation (1998) 1.55
Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res (1971) 1.55
Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology (1997) 1.51
Sites of adenosine production in cardiac and skeletal muscle. Am J Physiol (1973) 1.49
Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol (1989) 1.48
Brain adenosine concentration during hypoxia in rats. Am J Physiol (1981) 1.48
Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ Res (1971) 1.46
Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy. Eur Heart J (2001) 1.45
Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol (1985) 1.45
Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med (1995) 1.45
Adenosine in the local regulation of blood flow: a brief overview. Fed Proc (1983) 1.44
Adenosine and verapamil-sensitive ventricular tachycardia originating from the left ventricle: radiofrequency catheter ablation. Pacing Clin Electrophysiol (1992) 1.44
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation (1986) 1.41
Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration. J Clin Invest (1975) 1.40
Sciatic nerve stimulation does not increase endogenous adenosine production in sensory-motor cortex. J Cereb Blood Flow Metab (1992) 1.40
Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. Dig Liver Dis (2001) 1.39
Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation (1991) 1.38
Regional wall motion analysis predicts survival and functional outcome after subendocardial resection in patients with prior anterior myocardial infarction. Circulation (1993) 1.38
Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res (1983) 1.37
Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med (1980) 1.36
Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: a possible effect on Ca2+ influx. J Mol Cell Cardiol (1975) 1.30
Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation (1999) 1.30
Adenosine production in the ischemic kidney. Circ Res (1978) 1.29
Brain adenosine production in the rat during 60 seconds of ischemia. Circ Res (1979) 1.28
Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol (1999) 1.28
Adenosine and active hyperemia in dog skeletal muscle. Am J Physiol (1976) 1.27
Adenine nucleotide metabolism in the heart. Circ Res (1974) 1.27
Release of adenosine and lack of release of ATP from contracting skeletal muscle. Pflugers Arch (1975) 1.26
Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J Cereb Blood Flow Metab (1986) 1.26
Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J Physiol Heart Circ Physiol (2001) 1.26
Adenosine relaxation of isolated vascular smooth muscle. Am J Physiol (1976) 1.26
Atrioventricular conduction disturbances during hypoxia. Possible role of adenosine in rabbit and guinea pig heart. Circ Res (1980) 1.23
Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res (1999) 1.23
Effects of dispersive electrode position and surface area on electrical parameters and temperature during radiofrequency catheter ablation. Am J Cardiol (1996) 1.22
Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1994) 1.22
Regulation of coronary blood flow. Prog Cardiovasc Dis (1975) 1.21
A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J Lipid Res (1986) 1.20
Uptake and metabolism of adenosine by human erythrocyte ghosts. Am J Physiol (1972) 1.20
Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci (2001) 1.20
Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res (1984) 1.18
Propagated vasodilation in the microcirculation of the hamster cheek pouch. Circ Res (1970) 1.17
Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res (1982) 1.15
Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol (1975) 1.15
Release of adenosine from anoxic hearts. Relationship to coronary flow. Circ Res (1966) 1.14
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias. JAMA (1986) 1.13
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther (2001) 1.12
ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells. Am J Physiol (1993) 1.11
Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med (1983) 1.11
Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol (1999) 1.10
Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther (1999) 1.09
Changes in brain adenosine during bicuculline-induced seizures in rats. Effects of hypoxia and altered systemic blood pressure. Circ Res (1980) 1.09
Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol (1990) 1.08
Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia. Circulation (1987) 1.08
Intracardiac electrophysiologic techniques in recurrent syncope of unknown case. Ann Intern Med (1981) 1.07
Relationship between adenosine concentration and oxygen supply in rat brain. Am J Physiol (1975) 1.07
Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology (1991) 1.07
Relationship between coronary flow and adenosine production and release. J Mol Cell Cardiol (1974) 1.07
Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol Pharmacol (1998) 1.06
Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet (1998) 1.06
Adenosine-sensitive afterdepolarizations and triggered activity in guinea pig ventricular myocytes. Circ Res (1992) 1.05
Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology (1989) 1.05
Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ Res (1994) 1.05
Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc Res (1994) 1.05
Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut (2004) 1.04
Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pflugers Arch (1985) 1.03
Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for reentry within the upper portion of the atrioventricular node. J Am Coll Cardiol (1984) 1.03